Nicholas Pintori
Overview
Explore the profile of Nicholas Pintori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pintori N, Serra M, Carai A, Lobina C, Isola R, Noli R, et al.
Toxicology
. 2024 Jul;
507:153878.
PMID: 38972446
The use of synthetic cannabinoid receptor agonists (SCRAs) represents a public health concern. Besides abuse liability and cognitive impairments, SCRAs consumption is associated with serious medical consequences in humans, including...
2.
Piras G, Cadoni C, Caria F, Pintori N, Spano E, Vanejevs M, et al.
Int J Neuropsychopharmacol
. 2024 Mar;
27(5).
PMID: 38546531
Background: The proliferation of novel psychoactive substances (NPS) in the drug market raises concerns about uncertainty on their pharmacological profile and the health hazard linked to their use. Within the...
3.
Pintori N, Mostallino R, Spano E, Orru V, Piras M, Castelli M, et al.
J Neuroimmunol
. 2024 Mar;
389:578325.
PMID: 38432046
The use of synthetic cannabinoid receptor agonists (SCRAs) poses major psychiatric risks. We previously showed that repeated exposure to the prototypical SCRA JWH-018 induces alterations in dopamine (DA) transmission, abnormalities...
4.
Pintori N, Piva A, Mottarlini F, Castillo Diaz F, Maggi C, Caffino L, et al.
Eur J Neurosci
. 2024 Feb;
59(5):982-995.
PMID: 38378276
Environmental enrichment (EE) has been shown to produce beneficial effects in addiction disorders; however, due to its configurational complexity, the underlying mechanisms are not yet fully elucidated. Recent evidence suggests...
5.
Pintori N, Caria F, De Luca M, Miliano C
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982327
Cannabis is the most used drug of abuse worldwide. It is well established that the most abundant phytocannabinoids in this plant are Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). These two compounds...
6.
Margiani G, Castelli M, Pintori N, Frau R, Ennas M, Pagano Zottola A, et al.
Psychopharmacology (Berl)
. 2023 Mar;
240(5):1199.
PMID: 36928987
No abstract available.
7.
Tocco G, Laus A, Vanejevs M, Ture A, Mostallino R, Pintori N, et al.
Arch Pharm (Weinheim)
. 2022 Nov;
356(1):e2200432.
PMID: 36328777
The development of novel μ-opioid receptor (MOR) antagonists is one of the main objectives of drug discovery and development. Based on a simplified version of the morphinan scaffold, 3-[3-(phenalkylamino)cyclohexyl]phenol analogs...
8.
De Luca M, Tocco G, Mostallino R, Laus A, Caria F, Musa A, et al.
Neuropharmacology
. 2022 Sep;
221:109263.
PMID: 36154843
Recent trends of opioid abuse and related fatalities have highlighted the critical role of Novel Synthetic Opioids (NSOs). We studied the μ-opioid-like properties of isotonitazene (ITZ), metonitazene (MTZ), and piperidylthiambutene...
9.
Margiani G, Castelli M, Pintori N, Frau R, Ennas M, Pagano Zottola A, et al.
Psychopharmacology (Berl)
. 2022 Aug;
239(10):3083-3102.
PMID: 35943523
Rationale: The use of synthetic cannabinoid receptor agonists (SCRAs) is growing among adolescents, posing major medical and psychiatric risks. JWH-018 represents the reference compound of SCRA-containing products. Objectives: This study...
10.
Pintori N, Castelli M, Miliano C, Simola N, Fadda P, Fattore L, et al.
Br J Pharmacol
. 2021 Apr;
178(17):3476-3497.
PMID: 33837969
Background And Purpose: Spice/K2 herbal mixtures, containing synthetic cannabinoids such as JWH-018, have been marketed as marijuana surrogates since 2004. JWH-018 has cannabinoid CB receptor-dependent reinforcing properties and acutely increases...